Listen
Archive
2013
January
February
March
April
May
June
2012
January
February
March
April
May
June
July
August
September
October
November
December
2011
January
February
March
April
May
June
July
August
September
October
November
December
2010
January
February
March
April
May
June
July
August
September
October
November
December
2009
January
February
March
April
May
June
July
August
September
October
November
December
2008
January
February
March
April
May
June
July
August
September
October
November
December
2007
June
July
August
September
October
November
December
Subscribe
Jan. 23, 2009
First Human Clinical Trial of Embryonic Stem Cell Therapy Approved
|
|
|
Tweet |
| The FDA has given biotech company Geron permission to proceed with a human clinical trial of a therapy based on embryonic stem cells. The approval is the first of its kind in the world. The therapy to be tested in the Phase I trials, known as 'GRNOPC1,' will be used on human patients with acute spinal cord injury. GRNOPC1 contains oligodendrocyte progenitor cells derived from human embryonic stem cells. It will be injected directly into the lesion site of the patient's injured spinal cord in an attempt to restore spinal cord function. |
Produced by Christopher Intagliata, Associate Senior Producer



Discussion